Sabra Health Care REIT Given Consensus Rating of “Hold” by Brokerages (NASDAQ:SBRA)
Sabra Health Care REIT (NASDAQ:SBRA) has received an average rating of “Hold” from the ten brokerages that are covering the company, StockRatingsNetwork.com reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $31.25.
Sabra Health Care REIT (NASDAQ:SBRA) opened at 27.45 on Wednesday. Sabra Health Care REIT has a 1-year low of $21.55 and a 1-year high of $31.17. The stock has a 50-day moving average of $28.29 and a 200-day moving average of $28.42. The company has a market cap of $1.297 billion and a price-to-earnings ratio of 49.03.
Sabra Health Care REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, July 30th. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.55 by $0.02. The company had revenue of $42.97 million for the quarter, compared to the consensus estimate of $37.46 million. The company’s revenue for the quarter was up 33.1% on a year-over-year basis. Analysts expect that Sabra Health Care REIT will post $2.15 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, August 29th. Stockholders of record on Friday, August 15th will be paid a dividend of $0.38 per share. This represents a $1.52 annualized dividend and a dividend yield of 5.54%. The ex-dividend date is Wednesday, August 13th.
A number of analysts have recently weighed in on SBRA shares. Analysts at Jefferies Group raised their price target on shares of Sabra Health Care REIT from $33.00 to $34.00 in a research note on Tuesday, July 22nd. Separately, analysts at MLV & Co
initiated coverage on shares of Sabra Health Care REIT in a research note on Friday, June 27th. They set a “buy” rating and a $31.00 price target on the stock. Finally, analysts at Citigroup Inc. reiterated a “neutral” rating on shares of Sabra Health Care REIT in a research note on Tuesday, June 10th. They now have a $28.00 price target on the stock, up previously from $25.00.
Sabra Health Care REIT, Inc, a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (NASDAQ:SBRA) that, through its subsidiaries, owns and invests in real estate serving the healthcare industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.